Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $12.31 down -5.45% from its previous closing price of $13.02. In other words, the price has decreased by -$5.45 from its previous closing price. On the day, 2.17 million shares were traded. SPRY stock price reached its highest trading level at $12.76 during the session, while it also had its lowest trading level at $11.89.
Ratios:
For a deeper understanding of ARS Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 03 ’25 when Shawver Laura bought 50,000 shares for $12.31 per share.
Shawver Laura sold 50,000 shares of SPRY for $555,065 on Jan 06 ’25. The Director now owns 210,346 shares after completing the transaction at $11.10 per share. On Jan 06 ’25, another insider, Shawver Laura, who serves as the Director of the company, bought 50,000 shares for $11.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1196353536 and an Enterprise Value of 989945984. For the stock, the TTM Price-to-Sale (P/S) ratio is 465.51 while its Price-to-Book (P/B) ratio in mrq is 5.95. Its current Enterprise Value per Revenue stands at 385.493 whereas that against EBITDA is -16.378.
Stock Price History:
The Beta on a monthly basis for SPRY is 0.99, which has changed by 1.003077 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $6.17. The 50-Day Moving Average of the stock is -2.57%, while the 200-Day Moving Average is calculated to be 3.95%.
Shares Statistics:
For the past three months, SPRY has traded an average of 1.33M shares per day and 1405130 over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 51.12M. Insiders hold about 47.40% of the company’s shares, while institutions hold 42.79% stake in the company. Shares short for SPRY as of 1736899200 were 14810932 with a Short Ratio of 11.13, compared to 1734048000 on 12656935. Therefore, it implies a Short% of Shares Outstanding of 14810932 and a Short% of Float of 28.65.
